
- Level 1: What Does Swara Baby Products Actually Do?
- Level 2: Why Is Swara Baby Planning a ₹1,000 Crore IPO?
- Level 3: Why Does the FirstCry Connection Matter?
- Level 4: Swara Baby Is Already a Big Player Behind the Scenes
- Level 5: Baby Diapers Still Drive Most of the Business
- Level 6: How Are Swara Baby’s Revenue and Profits Growing?
- Level 7: Why Will Swara Baby’s IPO Valuation Matter?
- What Should Investors Check When Swara Baby's Updated IPO Documents Come Out?
- What This Means for Investors
- Swara Baby IPO: What Happens Next?
You probably know FirstCry as the place people shop for diapers, toys and baby products, but behind some of those products sits a company most consumers may never have heard of: Swara Baby Products. That company is now moving closer to Dalal Street after SEBI issued its observations for the planned ₹1,000 crore IPO. Swara Baby had filed its draft papers in July 2026, and the latest regulatory development allows the company to move ahead with the IPO process.
The proposed issue is split equally between new shares issued by the company and shares being sold by existing shareholders. Swara Baby plans a fresh issue of up to ₹500 crore and an Offer for Sale of ₹500 crore, with FirstCry parent Brainbees Solutions among the sellers. Brainbees’ official exchange filing also confirms that Swara Baby is its subsidiary and that the proposed IPO remains subject to market conditions and the required approvals.
The bigger story, however, is not just the IPO. Swara Baby has already built a sizeable manufacturing business and crossed ₹1,000 crore in annual revenue. The next stage is about whether the company can expand beyond its core diaper-manufacturing business and build a more diversified hygiene-products company before reaching public investors.
Level 1: What Does Swara Baby Products Actually Do?
Swara Baby is primarily a manufacturer of disposable hygiene products. Its factories make baby diapers, personal-care products for older users and women’s hygiene products such as sanitary napkins and panty liners. Much of this manufacturing happens for other brands, which means Swara Baby often works behind the scenes while another company's name appears on the final product.
Its customers include Brainbees Solutions, Piramal Pharma and Himalaya Wellness Company, according to the IPO documents. Swara Baby also sells products through its own brands, including Cuddles and Shield, giving the company two possible growth paths: manufacturing for established brands and gradually building a consumer presence of its own.
Level 2: Why Is Swara Baby Planning a ₹1,000 Crore IPO?
The planned IPO has two main parts. Swara Baby intends to raise up to ₹500 crore by issuing new shares, while another ₹500 crore is proposed through an Offer for Sale. Brainbees Solutions plans to sell shares worth up to ₹300 crore, while Anadya Bon Merchari LLP proposes to sell shares worth up to ₹200 crore.
For investors, the difference is important. Money raised through the fresh issue goes to Swara Baby and can be used for the business, while proceeds from the OFS go to the shareholders selling their shares. Swara Baby plans to use around ₹198 crore from the fresh issue for a new manufacturing facility in Madhya Pradesh, along with funds for reducing borrowings, supporting subsidiaries, possible acquisitions and other business requirements.
This means the planned IPO is not only about existing shareholders selling part of their holdings. A meaningful portion of the issue is intended to help fund Swara Baby’s next phase of growth.
Level 3: Why Does the FirstCry Connection Matter?
The FirstCry connection makes Swara Baby different from a typical standalone manufacturing company. Brainbees Solutions, the listed company behind FirstCry, held 76.59% of Swara Baby when the DRHP was filed. Brainbees is therefore not simply a famous name attached to the company; it is Swara Baby’s promoter, its largest shareholder and one of the shareholders proposing to sell part of its stake through the IPO.
The relationship began when Brainbees invested in Swara Baby in 2020 as part of its plan to build stronger manufacturing capabilities in diapers and gain greater control over product quality and production. Since then, Swara Baby has expanded to serve more brands and enter additional hygiene categories. Brainbees says the share of Swara Baby’s revenue coming from Brainbees itself declined from 27.03% in FY24 to 22.64% in FY26.
This is an important number to watch because it shows that Swara Baby is already doing business outside the FirstCry ecosystem. The updated IPO documents should show whether that dependence has reduced further.
Level 4: Swara Baby Is Already a Big Player Behind the Scenes
Swara Baby has already built significant scale in contract manufacturing. According to the industry data cited in its draft IPO papers, the company held around 37% of India's baby-diaper contract manufacturing market by value in FY25 and around 36% of the contract-manufacturing market for similar personal-care products used by older consumers.
The company operates four manufacturing facilities across Pithampur and Indore in Madhya Pradesh. This means Swara Baby is not planning an IPO while still trying to prove whether it can manufacture products at scale. It already has a sizeable position in a business where other brands depend on outside manufacturers to produce their products.
The more interesting question is what comes next. Manufacturing more products for existing customers can support growth, but building its own brands, winning additional customers and expanding into newer hygiene categories could give Swara Baby more than one source of future growth.
Level 5: Baby Diapers Still Drive Most of the Business
Even after expanding into other hygiene products, baby diapers remain Swara Baby’s biggest category. They accounted for around 79% of product sales in FY26, meaning the company's performance is still closely linked to this single segment.
Swara Baby has been trying to broaden its portfolio. Brainbees’ official filing says the company expanded its manufacturing capabilities into products for older users and women’s hygiene as its business grew. Swara Baby also acquired K.A. Enterprises Hygiene in December 2025, adding further manufacturing capabilities in women’s hygiene products.
This gives investors another trend to follow. If these newer categories gradually become a larger part of sales, Swara Baby could become less dependent on baby diapers. If the revenue mix remains largely unchanged, baby care will continue to determine most of the company's growth.
Level 6: How Are Swara Baby’s Revenue and Profits Growing?
Swara Baby reported revenue from operations of around ₹1,164 crore in FY26, compared with about ₹943 crore in FY25. Profit after tax increased to about ₹96 crore from roughly ₹81 crore during the same period. Brainbees’ own stock-exchange filing independently confirms Swara Baby’s FY26 revenue from operations at ₹11,639 million, or about ₹1,164 crore.
These numbers show that the business grew in FY26, but investors will eventually need more than one year of growth to understand the company. The updated financials should show whether profits continue to grow alongside sales, whether the business generates healthy cash after spending on factories, and how borrowings change as the company expands.
Those questions will become even more relevant once Swara Baby announces the valuation at which it plans to sell shares to public investors.
Level 7: Why Will Swara Baby’s IPO Valuation Matter?
Receiving SEBI observations does not mean investors can apply for the Swara Baby IPO today. The company still needs to complete the remaining steps before announcing the price band, bidding dates, lot size and other final offer details. The October 6 regulatory development allows the company to move ahead with the issue process, but the IPO remains a planned offering at this stage.
That also means it is too early to judge whether the planned IPO will be cheap or expensive. Investors first need to know what valuation Swara Baby seeks and then compare that price with the company’s latest profits, growth and financial position.
The business can be studied today. The valuation question can only be answered when the pricing becomes available.
What Should Investors Check When Swara Baby's Updated IPO Documents Come Out?
The DRHP will matter much more than today's reported estimates.
Investors should focus on:
- Final valuation: How much are investors being asked to pay compared with Swara Baby’s latest earnings and growth?
- Latest financials: Have revenue and profit continued to grow after FY26?
- Brainbees stake: How much of Swara Baby will FirstCry parent Brainbees retain after the IPO?
- Customer concentration: Has the share of business coming from Brainbees and other large customers increased or decreased?
- Own brands: Are Cuddles and Shield becoming meaningful parts of the business, or does manufacturing for other brands still dominate?
- Product mix: Is Swara Baby becoming less dependent on baby diapers as other hygiene categories grow?
- Debt: How much borrowing remains after the planned use of IPO proceeds?
- New factory: How much additional production can the planned Madhya Pradesh facility support, and how quickly can that capacity be used?
Brainbees has said that Swara Baby is pursuing a separate listing because its growing product range, expansion into more channels and international markets have created different capital requirements from the original FirstCry-linked business. The updated IPO documents should help investors see how far that transition has progressed.
What This Means for Investors
Swara Baby approaches its planned IPO with an established manufacturing business, a strong connection with FirstCry and a sizeable position in contract manufacturing. At the same time, baby diapers continue to generate most of its product sales, while Brainbees remains an important customer as well as the company's promoter.
There are signs that the business is gradually becoming broader. Swara Baby has added customers, moved into additional hygiene categories and reduced the percentage of revenue coming from Brainbees between FY24 and FY26. Whether that trend continues will be clearer when the company publishes updated financial and operating information closer to the IPO.
For investors, the FirstCry connection helps explain how Swara Baby reached its current scale, but the eventual IPO price, latest financials, customer mix, debt and use of new manufacturing capacity will be more relevant when evaluating the issue itself.
Swara Baby IPO: What Happens Next?
SEBI’s observations move Swara Baby one step closer to the stock market, but the proposed ₹1,000 crore IPO is still a planned issue rather than an open offer. Investors will need to wait for the next filings to know the final IPO dates, price band, lot size and valuation.
For now, the FirstCry name makes Swara Baby easy to notice. The bigger story to track is whether the company can continue expanding beyond its original role as a diaper manufacturer and build a broader hygiene-products business before asking public investors to decide what that business is worth.
For more open and upcoming IPOs, visit INDmoney’s IPO tracker.